Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Good news tomorrow
View:
Post by subaru1 on Aug 13, 2023 4:30pm

Good news tomorrow

First we get the 2 qrt results before the market open and secondly the Hexo court appeal, hopefully if we do have good results and we win the Hexo appeal we should move over $0,10 quickly. Come on monday.....
Comment by subaru1i on Aug 13, 2023 7:24pm
Did anyone else notice?  LABS shifted their earnings reporting from a Wed/Thurs routine to a Monday routine.  I believe this is the second time they've now done it on a Monday?    It could be an interesting week, and who knows, the drug monograph after earnings because technically LABS may already have the drug monograph from the FDA but is sitting on the news until ...more  
Comment by mdjbrown on Aug 13, 2023 9:41pm
s1, rumor has it on another investment site that the HEXO appeal hearing has been moved to October 12, 2023. Guess we will likely find out in less than 12 hours.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities